MedTrace Logo

Lipid Lowering Effect of Plant Stanol Ester in a Drinkable Non-dairy Product

NCT05126056 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2021-12-03

No results posted yet for this study

Summary

The aim is to determine the effect of investigational products on serum LDL cholesterol.

Conditions

Interventions

OTHER

Plant stanol ester

Product with active ingredient vs product without active ingredient

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Raisio Group

    lead INDUSTRY

Principal Investigators

  • Helena Gylling · Helsinki University Hospital, Helsinki, Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2021-11-30
Completion
2021-12-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05126056 on ClinicalTrials.gov